Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study

---

KİM H. J., PİTTOCK S. J., BERTHELE A., FUJİHARA K., LEVY M., PALACE J., ...More

Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 February 2020, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Ondokuz Mayıs University Affiliated: Yes